Description

Dibizid-M (metformin hydrochloride and glipizide) tablets №60

Ingredients

Dibizid-M tablets contain metformin hydrochloride and glipizide as active ingredients.

Dosage

The recommended dosage of Dibizid-M is determined by a healthcare provider based on individual needs. It is typically taken orally with food to reduce the risk of gastrointestinal side effects.

Indications

Dibizid-M tablets are indicated for the management of type 2 diabetes mellitus to improve glycemic control.

Contraindications

Do not use Dibizid-M tablets if you have a history of allergic reactions to metformin or glipizide, severe kidney disease, or metabolic acidosis.

Directions

Follow the instructions provided by your doctor for the proper use of Dibizid-M tablets. Do not exceed the recommended dose to avoid potential adverse effects.

Scientific Evidence

Studies have shown that the combination of metformin and glipizide in Dibizid-M tablets can effectively lower blood glucose levels in patients with type 2 diabetes. The synergistic action of these two medications helps improve insulin sensitivity and reduce hepatic glucose production.

Clinical trials have demonstrated the efficacy of Dibizid-M in achieving and maintaining glycemic control, leading to improved outcomes in diabetic patients. The dual mechanism of action of metformin and glipizide makes Dibizid-M a valuable option for diabetes management.

Additional Information

It is important to monitor blood glucose levels regularly while taking Dibizid-M tablets to adjust the dosage as needed. Inform your healthcare provider about any changes in your health status or medication regimen.

Consult your doctor for personalized advice on the use of Dibizid-M and to discuss any potential drug interactions or side effects. Maintaining a healthy lifestyle with proper diet and exercise is essential for optimal diabetes management.